Mary Ellen Estes, NP
Nurse Practitioner · Fairfax, VANPI 1447427000
Payments from drug & device makers
Across 192 payments — averaging $23.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$576
- Pfizer$546
- Novo Nordisk$498
- Amgen$273
- Johnson & Johnson$265
- Lilly USA, LLC$238
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,420100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $576 |
| Pfizer | 22 | $546 |
| Novo Nordisk | 23 | $498 |
| Amgen | 15 | $273 |
| Johnson & Johnson | 14 | $265 |
| Lilly USA, LLC | 13 | $238 |
| Boehringer Ingelheim | 10 | $220 |
| AstraZeneca | 7 | $209 |
| Bausch Health US, LLC | 8 | $158 |
| Sanofi | 1 | $111 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Esperion Therapeutics, Inc. | 6 | $100 |
| Gilead | 2 | $96 |
| Vanda Pharmaceuticals Inc. | 4 | $85 |
| Biohaven Pharmaceuticals, Inc. | 4 | $84 |
| Abbott | 3 | $67 |
| Sage Therapeutics, LLC | 1 | $67 |
| Sanofi-aventis U.S. LLC | 3 | $61 |
| Daiichi Sankyo Inc. | 3 | $59 |
| Exact Sciences | 3 | $57 |
| Kaleo, Inc. | 2 | $46 |
| Mylan Specialty L.p. | 2 | $45 |
| Novartis | 2 | $40 |
| Amarin Pharma, Inc. | 2 | $37 |
| GSK | 2 | $36 |
| Amneal Pharmaceuticals LLC | 2 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| IBSA Pharma Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,420 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $219 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Fairfax
- Pamela StenborgFairfax$8K
- Wendy HoltFairfax$7K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
- Rachel AndersonCharlottesville$90K
- Megan FrancisArlington$81K
- Elizabeth WilletteNorfolk$58K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.